JPMorgan’s quant guru details 2 ways Trump’s COVID-19 diagnosis can lift markets

Marko Kolanovic Top 100
  • President Donald Trump’s COVID-19 diagnosis could improve the stock market’s outlook in two ways, Marko Kolanovic, the head of quantitative and derivatives strategy at JPMorgan, said Friday.
  • In one hypothetical scenario posed by the bank, a mix of voter sympathy, increased turnout, and mild coronavirus symptoms could lift Trump’s odds of winning a second term.
  • A Trump victory would vindicate the president’s efforts to rapidly reopen the economy, Kolanovic said.
  • A more serious infection could lower tensions between Democrats and Republicans and boost Republicans’ odds of winning congressional elections, the strategist added.
  • Visit the Business Insider homepage for more stories.

President Donald Trump’s COVID-19 diagnosis jolted markets, but its lasting effects could aid bullish investors, according to JPMorgan.

In a note on Friday, the bank held its year-end S&P 500 target of 3,600, adding the diagnosis only slightly increases the Democratic presidential nominee Joe Biden’s chances of taking the White House in November.

Biden has had a healthy lead in many polls, and a boost might aid markets by reducing election-related uncertainty, the team led by Marko Kolanovic, the head of quantitative and derivatives strategy at JPMorgan, said in a note.

Read more: BANK OF AMERICA: Buy these 29 high-quality value stocks primed to cash in on the economic recovery

Two hypothetical outcomes for Trump’s infection stand to create an even more positive environment for stocks, the team added. A cocktail of voter sympathy, increased turnout, and a mild COVID-19 case could lift Trump’s election odds. The president would be able to boast that his reopening plans were correct and push forward with his economic recovery efforts, Kolanovic said.

Such a scenario isn’t without precedent. UK Prime Minister Boris Johnson enjoyed an outpouring of public sympathy after contracting the virus in March. After a debate performance largely viewed as chaotic and detrimental to his election hopes, Trump could regain some favor among voters.

The bank’s second hypothetical hinges on a more dire outcome. Should Trump suffer significantly from the virus, that could ease tensions and build new partnerships between Democrats and Republicans. The president’s worsening condition could give way to “national reconciliation” and raise the election odds for Republicans running for Congress, the strategists added.

Read more: Morgan Stanley’s wealth-management CIO says tech stocks won’t provide a ‘port in the storm’ of market volatility — and gives her best recommendations for where else investors can go, both short and long term

Either way, JPMorgan expects the market’s outlook to improve through the end of the year. Positioning in stocks relative to other assets remains low. The bank sees the probability of an early stimulus deal increasing, despite Senate Republicans balking at the $2.2 trillion measure that House Democrats passed on Thursday.

Third-quarter earnings and guidance should “remain constructive” as profits beat expectations and companies’ balance sheets strengthen, the team added.

Now read more markets coverage from Markets Insider and Business Insider:

Peter Mallouk built a $34 million RIA into a $50 billion giant. The wealth-management CEO pinpoints 3 opportunities his firm is implementing in client portfolios, and shares 2 tips on how to accumulate wealth.

A Wall Street chief strategist breaks down what Trump’s COVID-19 diagnosis means for markets

US economy misses forecasts, adds 661,000 jobs in September as unemployment falls to 7.9%

Read More: JPMorgan’s quant guru details 2 ways Trump’s COVID-19 diagnosis can lift markets

Notify of
Inline Feedbacks
View all comments

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.